Skip to content

Clinical trials

Phase 2/3 Reperfusion Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Phase: Phase 2/3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20112
20171
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc1
Boston Children's Hospital1
Helsinki University Central Hospital1
Ludwig-Maximilians - University of Munich1
Nkanyiso Hadebe1
United Therapeutics1
University of Alabama at Birmingham1
iCoat Medical AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury8
Heart Defects, Congenital1
Heart Failure1
Inflammation1
Liver Failure1
Renal Insufficiency1
Respiratory Insufficiency1

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.